Human Papillomavirus Prevalence Among 88 Male Virgins Residing in Brazil, Mexico, and the United States
Carregando...
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
OXFORD UNIV PRESS INC
Autores
LIU, Zhiyue
NYITRAY, Alan G.
HWANG, Lu-Yu
SWARTZ, Michael D.
ABRAHAMSEN, Martha
LAZCANO-PONCE, Eduardo
SALMERN, Jorge
QUITERIO, Manuel
Citação
JOURNAL OF INFECTIOUS DISEASES, v.214, n.8, p.1188-1191, 2016
Resumo
This study determined the prevalence and risk factors for genital human papillomavirus (HPV) detection among men who deny ever engaging in penetrative sex. A questionnaire was administered to 4123 men from a cohort study of HPV natural history. Genital exfoliated cells were collected and genotyped for 36 HPV types. Eighty-eight men were classified as virgins. Log-binomial regression models identified factors associated with genital HPV detection. The prevalence of any and high-risk HPV types among 88 male virgins was 25.0% and 18.2%, respectively. Age and smoking status were associated with HPV detection. Further studies are needed to better understand the risk for HPV infection among male virgins.
Palavras-chave
human papillomavirus, male, virgins, prevalence, risk factors
Referências
- Chandra A, 2011, NATL HLTH STAT REPOR, V36, P1
- Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777
- Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151
- Giuliano AR, 2010, GYNECOL ONCOL, V117, pS15, DOI 10.1016/j.ygyno.2010.01.026
- Hernandez BY, 2008, EMERG INFECT DIS, V14, P888, DOI 10.3201/eid1406.070616
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC MON EV CARC RIS, V100, P255
- Lazcano-Ponce E, 2001, SEX TRANSM DIS, V28, P277, DOI 10.1097/00007435-200105000-00007
- Liu ZY, 2016, SEX HEALTH, V13, P10, DOI 10.1071/SH15089
- Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9
- Schabath MB, 2012, CANCER EPIDEM BIOMAR, V21, P102, DOI 10.1158/1055-9965.EPI-11-0591
- Schuster MA, 1996, AM J PUBLIC HEALTH, V86, P1570, DOI 10.2105/AJPH.86.11.1570
- Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803
- Svare EI, 2002, SEX TRANSM INFECT, V78, P215, DOI 10.1136/sti.78.3.215
- Vaccarella S, 2006, INT J CANCER, V119, P1934, DOI 10.1002/ijc.21992
- Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180